SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.
Announcement of the company's financial officer,
accounting officer and corporate governance officer
approved by Board of Directors.
Date of events
2022/06/29
To which item it meets
paragraph 8
Statement
1.Type of personnel changed (please enter: spokesperson, acting
spokesperson, important personnel (CEO, COO, CMO, CSO, etc.)
,financial officer, accounting officer, corporate governance officer,
research and development officer, chief internal auditor, or
designated and non-designated representatives):financial officer/
accounting officer/corporate governance officer.
2.Date of occurrence of the change:2022/06/29
3.Name, title, and resume of the previous position holder:None.
4.Name, title, and resume of the new position holder:Guo,Ru-Ling,Vice
President.
5.Type of the change (please enter: "resignation", "position
adjustment", "dismissal", "retirement", "death" or "new
replacement"): new replacement
6.Reason for the change: new replacement
7.Effective date:2022/06/29
8.Any other matters that need to be specified:None.
Attachments
Original Link
Original Document
Permalink
Disclaimer
SciVision Biotech Inc. published this content on 29 June 2022 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 29 June 2022 11:37:02 UTC.
SciVision Biotech Inc is principally engaged in the manufacturing and distribution of hyaluronic acid medical supplies. The Company primarily provides subcutaneous fillers for plastic surgery facial injection, joint cavity injections for orthopedics use, as well as hyaluronic acid raw materials, among others. The Company is also involved in deoxyribonucleic acid (DNA) identification, detection, sequencing and application, as well as the manufacturing of care products and foods. The Company operates its business in the Americas, Europe, Asia, Middle East and Africa.
SciVision Biotech : Announcement of the company's financial officer, accounting officer and corporate governance officer approved by Board of Directors.